Search research articles
Contact Us
Filters
Showing results (351-360 of 692) with videos related to
Page
of 70
Sort By:
Urology
|
May 29, 2002
Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer
Michael J Morris, Timothy Akhurst, Iman Osman, et al.
Journal of Clinical Epidemiology
|
January 1, 1988
Day hospital as an alternative to inpatient care for cancer patients: a random assignment trial
V Mor, M Z Stalker, R Gralla, et al.
Cancer
|
August 1, 1984
Estrogen, progesterone, and androgen-binding sites in renal cell carcinoma. Observations obtained in Phase II trial of flutamide
T Ahmed, P Benedetto, A Yagoda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1990
Trimetrexate in prostatic cancer: preliminary observations on the use of prostate-specific antigen and acid phosphatase as a marker in measurable hormone-refractory disease
H I Scher, T Curley, N Geller, et al.
Cephalalgia : an International Journal of Headache
|
March 11, 2020
The prevalence of hypnic headache in Iceland
Jon H Eliasson, Ann I Scher, Dawn C Buse, et al.
European Urology Focus
|
February 27, 2026
ARAMON, a phase 2 open-label trial of darolutamide monotherapy in patients with biochemical recurrence or oligometastatic castration-sensitive prostate cancer after radical prostatectomy or primary radiotherapy
Andrew L Laccetti, Matthew R Smith, Howard I Scher, et al.
Biochimica Et Biophysica Acta
|
February 27, 1986
Influence of vesicle size on complement-dependent immune damage to liposomes
R L Richards, R C Habbersett, I Scher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma
P M Dodd, J A McCaffrey, H Herr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2014
Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial
C N Sternberg, J S de Bono, K N Chi, et al.
The Prostate
|
December 16, 1997
Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue
T Bogenrieder, C L Finstad, R H Freeman, et al.
Page
of 70
Search research articles
Search
Showing results (351-360 of 692) with videos related to
Sort By:
Page
of 70
Urology
|
May 29, 2002
Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer
Michael J Morris, Timothy Akhurst, Iman Osman, et al.
Journal of Clinical Epidemiology
|
January 1, 1988
Day hospital as an alternative to inpatient care for cancer patients: a random assignment trial
V Mor, M Z Stalker, R Gralla, et al.
Cancer
|
August 1, 1984
Estrogen, progesterone, and androgen-binding sites in renal cell carcinoma. Observations obtained in Phase II trial of flutamide
T Ahmed, P Benedetto, A Yagoda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1990
Trimetrexate in prostatic cancer: preliminary observations on the use of prostate-specific antigen and acid phosphatase as a marker in measurable hormone-refractory disease
H I Scher, T Curley, N Geller, et al.
Cephalalgia : an International Journal of Headache
|
March 11, 2020
The prevalence of hypnic headache in Iceland
Jon H Eliasson, Ann I Scher, Dawn C Buse, et al.
European Urology Focus
|
February 27, 2026
ARAMON, a phase 2 open-label trial of darolutamide monotherapy in patients with biochemical recurrence or oligometastatic castration-sensitive prostate cancer after radical prostatectomy or primary radiotherapy
Andrew L Laccetti, Matthew R Smith, Howard I Scher, et al.
Biochimica Et Biophysica Acta
|
February 27, 1986
Influence of vesicle size on complement-dependent immune damage to liposomes
R L Richards, R C Habbersett, I Scher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma
P M Dodd, J A McCaffrey, H Herr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2014
Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial
C N Sternberg, J S de Bono, K N Chi, et al.
The Prostate
|
December 16, 1997
Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue
T Bogenrieder, C L Finstad, R H Freeman, et al.
Page
of 70